Krishnan, Jerry A <br/><br/>
Omalizumab for severe allergic asthma: dollars and sense.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Nov 2007 
 - 1015-7 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1097-6825 
<br/><br/><label>Standard No.: </label>10.1016/j.jaci.2007.09.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Asthmatic Agents--economics<br/>Antibodies, Anti-Idiotypic<br/>Antibodies, Monoclonal--economics<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Humans<br/>Omalizumab<br/>Respiratory Hypersensitivity--drug therapy